Hizentra (2020-01-16)
- Starting date:
- January 16, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs, Biologic/vaccine
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-72153
Last updated: 2020-01-17
Summary
- Product: Hizentra, also known as immune globulin (human) 10 ml single used prefilled syringes
Reason
Atypical appearance (viscous or gelatinous solution) of product in affected lot.
Depth of distribution
End users
Affected products
Hizentra, also known as immune globulin (human) 10 ml single used prefilled syringes
DIN, NPN, DIN-HIM
DIN 02463067Dosage form
Solution
Strength
Immunoglobulin (Human) 200 mg/mL
Lot or serial number
P100047093
Companies
- Recalling Firm
-
CSL Behring Canada Inc.
Suite 1460, 55 Metcalfe Street,
Ottawa
K1P 6L5
Ontario
CANADA
- Marketing Authorization Holder
-
CSL Behring Canada Inc.
Suite 1460, 55 Metcalfe Street,
Ottawa
K1P 6L5
Ontario
CANADA